Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

0.44USD
9:00pm BST
Change (% chg)

$-0.02 (-3.93%)
Prev Close
$0.46
Open
$0.48
Day's High
$0.48
Day's Low
$0.42
Volume
313,576
Avg. Vol
354,417
52-wk High
$2.27
52-wk Low
$0.42

Latest Key Developments (Source: Significant Developments)

Curis Inc Says James Dentzer Became COO And CFO Of Co
Thursday, 22 Mar 2018 

March 22 (Reuters) - Curis Inc ::CURIS SAYS ON MARCH 21, JAMES DENTZER BECAME CHIEF OPERATING OFFICER AND CFO OF CO - SEC FILING.CURIS INC - DENTZER BECAME CFO IN CONNECTION WITH ENTRANCE INTO AN AMENDED AND RESTATED EMPLOYMENT AGREEMENT.  Full Article

Curis Q4 Loss Per Share $0.05
Thursday, 8 Mar 2018 

March 8 (Reuters) - Curis Inc ::CURIS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS.Q4 REVENUE $3.3 MILLION.Q4 LOSS PER SHARE $0.05.  Full Article

Curis Inc says Q3 loss per share $0.11
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Curis Inc -:Curis reports third quarter 2017 financial results.Q3 revenue $2.4 million versus I/B/E/S view $2.2 million.Q3 loss per share $0.11.Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Curis Inc - ‍announce Acceptance Of Investigational New Drug (IND) application for CA-4948​.  Full Article

Curis announces pricing of public offering of common stock
Thursday, 14 Sep 2017 

Sept 14 (Reuters) - Curis Inc :Curis Inc - pricing of an underwritten public offering of 20 million shares of its common stock​.  Full Article

Curis announces proposed public offering of common stock
Wednesday, 13 Sep 2017 

Sept 13 (Reuters) - Curis Inc :Curis announces proposed public offering of common stock.Curis Inc says ‍intention to offer and sell up to 20 million shares of its common stock in an underwritten public offering.Curis Inc- Intends to use net proceeds to continue development of CUDC-907, as well as CA-170, CA-327 and CA-4948.  Full Article

Curis reports Q2 loss per share $0.10
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - Curis Inc :Curis reports second quarter 2017 financial results.Q2 revenue $2.1 million versus i/b/e/s view $2.1 million.Q2 loss per share $0.10.Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.  Full Article

Cara Therapeutics appoints Mani Mohindru CFO
Tuesday, 1 Aug 2017 

Aug 1 (Reuters) - Cara Therapeutics Inc ::Cara Therapeutics appoints Mani Mohindru, Ph.D., chief financial officer.Josef Schoell, who has held CFO position at Cara for more than a decade, will be retiring.Most recently, Mohindru served as chief strategy officer at Curis, Inc.  Full Article

Curis Q1 loss per share $0.11
Thursday, 4 May 2017 

May 4 (Reuters) - Curis Inc :Curis reports first quarter 2017 financial results.Q1 revenue $2.1 million versus i/b/e/s view $2 million.Q1 loss per share $0.11.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Curis inc qtrly loss per share $0.11.Curis inc - revenues for q1 of 2017 were $2.1 million as compared to $1.7 million for same period in 2016.  Full Article

Curis Q4 loss per share $0.08
Thursday, 9 Mar 2017 

Curis Inc : Curis reports fourth quarter and year-end 2016 financial results . Q4 revenue $2.4 million . Q4 revenue view $1.9 million -- Thomson Reuters I/B/E/S . Q4 loss per share $0.08 . Q4 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S .Curis inc - company announces $45 million debt transaction with healthcare royalty partners secured with future erivedge(®) royalty.  Full Article

Curis files for resale of up to 10.2 mln shares by selling stockholder
Monday, 5 Dec 2016 

Curis Inc :Files for resale of up to 10.2 million shares of co's common stock by the selling stockholder.  Full Article

BRIEF-Curis Files For Mixed Shelf Of Upto $200 Mln

* CURIS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/2rkihf5) Further company coverage: